Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP) trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2/3

NCT07656909

Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP

This randomized clinical trial evaluates if low-dose sirolimus (target trough 4-8 ng/mL) combined with prednisolone is noninferior in efficacy but superior in s…

China76 participantsStarted 2026-06-16Updated 2026-06-18

Treatment: Sirolimus (RAPAMUNE)

All recent trials (2 shown)

UnknownPhase 1

NCT04409691

SCMC Trial on KHE With KMP (V.2020)

a phase I trial focusing on safety and efficacy of prednison shock plus sirolimus maintenance in treating Kaposiform hemangioendothelioma (KHE) with Kasabach-Me…

China20 participantsStarted 2020-07-01Updated 2020-06-09

Treatment: prednison and Sirolimus, prednison